Thymoma associated with autoimmune diseases: 85 cases and literature review

Archive ouverte

Bernard, C. | Frih, H. | Pasquet, F. | Kerever, S. | Jamilloux, Y. | Tronc, F. | Guibert, B. | Isaac, S. | Devouassoux, M. | Chalabreysse, L. | Broussolle, C. | Petiot, P. | Girard, Nicolas | Seve, P.

Edité par CCSD ; Elsevier -

International audience. OBJECTIVES: To describe the clinical features, treatment, and outcome of autoimmune diseases (AD) in a cohort of patients with thymoma. DESIGN: Pathological records from three university hospitals, between 2005 and 2011, were reviewed to identify patients with thymoma. Patients with thymoma and AD were compared with patients with thymoma without AD. RESULTS: 47/85 (55%) cases of thymoma had AD, including myasthenia gravis (MG) (n=33), Hashimoto's thyroiditis (n=4), Isaac's syndrome (n=3), Morvan syndrome (n=2), pure red cell aplasia (n=2), systemic lupus (n=2), lichen planus (n=2), and one case of each following conditions: aplastic anemia, autoimmune hemolytic anemia, Good's syndrome, pemphigus, autoimmune hepatitis, Graves' disease, limbic encephalitis, and inflammatory myopathy. Six patients (7%) presented at least 2 ADs. The median duration of follow-up after surgery was 60months (40-78months). In 32 patients, the diagnosis of AD preceded the diagnosis of thymoma, in 9 patients, thymoma was diagnosed at the same time as the AD and 7 patients had been operated on when they developed an AD. We found a significative difference on the Masaoka stage between the MG patients and the patients who present another AD (p=0.028). No risk factor for developing an AD after thymectomy was identified. CONCLUSIONS: We describe here the long-term follow-up of a large series of AD related to thymoma. Our results confirm previous data concerning AD occurrence in patients with thymoma and suggest that preexisting autoimmunity is not a risk factor for developing autoimmune manifestations after thymectomy

Consulter en ligne

Suggestions

Du même auteur

[Thymoma and autoimmune diseases]

Archive ouverte | Jamilloux, Y. | CCSD

International audience. The association between thymoma and autoimmunity is well known. Besides myasthenia gravis, which is found in 15 to 20% of patients with thymoma, other autoimmune diseases have been reported: ...

Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine

Archive ouverte | Jamilloux, Y. | CCSD

International audience. BACKGROUND AND OBJECTIVES: Progressive multifocal leukoencephalopathy (PML) is a rare, JC-virus-mediated, demyelinating disease with a high mortality rate. As no recommended treatment exists,...

Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis

Archive ouverte | Jamilloux, Y. | CCSD

International audience. We evaluated mortality rates and underlying causes of death among French decedents with sarcoidosis from 2002 to 2011.We used data from the French Epidemiological Centre for the Medical Cause...

Chargement des enrichissements...